64

Pegavision

6491 · TW · Healthcare / Medical Instruments & Supplies

392.50TWD+7.00 (+1.82%)

Price History

Full chart

Market Stats

Previous Close385.50
Open387.50
Day Range387.50 – 399.00
52-Week Range263.36 – 428.00
Volume158.56K
Market Cap32.58B
P/E (TTM)17.99
Forward P/E0.00
EPS23.57
Dividend Yield2.36%
Beta0.81
50-Day Avg378.80
200-Day Avg320.04

About

Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation operates as a subsidiary of Pegatron Corporation.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Ming-Dong Kuo
  • Employees0
  • Headquarters2F.-1, Taoyuan City, Taiwan, 33341, Taiwan
  • Websitehttps://www.pegavision.com

Leadership

  • Mr. Ming-Dong KuoChairman of the Board & Chief Strategy Officer
  • Mr. Te-Sheng YangPresident & Representative Director
  • Mr. Tony WangSenior Director of Finance & Accounting Div., Accounting Supervisor and Corporate Governance Officer
  • Mr. Terry ChangVice President
  • Ms. Yi-Hong PanDeputy General Manager

Financials

Income Statement

Currency: TWD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue229.73M589.32M920.93M1.31B1.66B2.18B3.13B3.36B3.98B5.60B6.32B6.79B6.82B7.04B
Growth (%)-+156.52%+56.27%+41.99%+26.90%+31.51%+43.56%+7.10%+18.58%+40.64%+12.98%+7.41%+0.40%+3.26%
Cost of Revenue120.13M276.39M478.45M638.11M819.17M1.13B1.53B1.86B1.97B2.63B3.01B3.12B2.99B3.49B
Gross Profit109.61M312.93M442.49M669.50M840.17M1.05B1.61B1.49B2.00B2.96B3.32B3.67B3.82B3.55B
Gross Margin47.71%53.10%48.05%51.20%50.63%48.10%51.25%44.50%50.39%52.98%52.45%54.03%56.09%50.36%
Operating Expense158.18M264.55M369.16M511.57M601.91M680.12M832.19M911.71M1.15B1.51B1.48B1.69B1.78B1.74B
Operating Income-48.58M48.38M73.33M157.94M238.26M369.47M773.17M581.32M852.37M1.46B1.83B1.98B2.05B1.81B
Operating Margin-21.14%8.21%7.96%12.08%14.36%16.93%24.68%17.33%21.42%26.05%29.00%29.18%30.00%25.67%
EBITDA-13.34M130.04M202.60M365.55M482.49M637.28M1.29B1.27B1.46B2.11B2.77B2.96B2.92B2.85B
EBITDA Margin-5.80%22.07%22.00%27.96%29.08%29.20%41.11%37.80%36.73%37.78%43.75%43.61%42.83%40.44%
Net Income-34.93M44.64M68.96M127.11M186.89M302.91M541.16M475.49M715.36M1.25B1.54B1.66B1.83B1.63B
Net Income Margin-15.20%7.58%7.49%9.72%11.26%13.88%17.27%14.17%17.98%22.32%24.40%24.39%26.85%23.13%
R&D73.27M110.96M138.60M200.87M224.59M230.40M237.96M279.80M374.46M546.64M575.92M592.39M646.17M622.75M
R&D as % of Total Revenue31.89%18.83%15.05%15.36%13.53%10.56%7.60%8.34%9.41%9.77%9.11%8.72%9.48%8.85%
Interest Expense-3.74M4.37M4.58M3.42M2.89M9.92M22.16M3.96M4.46M22.53M45.53M59.75M53.27M
Interest Expense % of Total Revenue-0.63%0.47%0.35%0.21%0.13%0.32%0.66%0.10%0.08%0.36%0.67%0.88%0.76%

Balance Sheet

Currency: TWD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.57B1.03B1.57B1.72B1.93B2.91B4.15B5.31B6.42B8.56B9.56B13.86B14.55B16.17B
Total Liabilities655.18M486.14M655.18M678.17M701.97M1.44B2.14B1.26B1.82B3.06B3.08B3.88B3.49B4.44B
Total Equity915.43M546.10M915.43M1.04B1.23B1.47B2.01B4.05B4.60B5.49B6.43B9.91B10.97B11.63B
Cash383.63M183.45M383.63M307.42M259.08M585.27M430.00M812.81M1.25B1.85B1.85B1.50B2.00B1.71B
Total Debt172.60M202.04M172.60M180.40M119.59M146.33M648.18M304.72M489.39M750.68M1.02B1.55B1.01B1.15B
Net Debt-211.03M18.59M-211.03M-127.02M-139.49M-438.94M218.18M-508.08M-756.61M-1.10B-829.50M47.12M-994.53M-556.36M

Cash Flow

Currency: TWD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow14.64M42.65M202.34M354.39M148.87M1.05B1.11B772.52M1.19B2.63B2.05B799.48M4.20B2.61B
Investing Cash Flow-155.01M-334.57M-316.32M-433.89M-96.52M-681.54M-1.83B-1.19B-719.03M-1.85B-1.43B-3.40B-2.48B-2.15B
Financing Cash Flow310.75M214.09M313.79M3.20M-96.61M-36.96M563.14M806.63M-43.83M-172.25M-623.26M2.27B-1.23B-766.36M
Capital Expenditure140.41M302.17M306.37M468.98M91.64M648.37M1.74B1.27B715.93M1.85B1.43B1.28B3.45B1.47B
Free Cash Flow-125.77M-259.51M-104.03M-114.59M57.23M397.21M-632.70M-498.07M478.28M780.27M618.02M-484.77M747.33M1.14B
Dividends Paid-----60.00M90.00M90.00M175.00M350.00M595.00M707.50M780.00M858.00M
FCF to OCF-859.17%-608.42%-51.42%-32.33%38.44%37.99%-56.94%-64.47%40.05%29.64%30.18%-60.64%17.79%43.69%
Dividend Paid to FCF-----15.11%-14.22%-18.07%36.59%44.86%96.27%-145.95%104.37%75.11%

Earnings

Report DateOct 29, 2019Feb 10, 2020Apr 27, 2020Jul 27, 2020Oct 26, 2020Jan 29, 2021Apr 26, 2021Jul 26, 2021Oct 28, 2021Feb 15, 2022Apr 25, 2022Jul 25, 2022Oct 31, 2022Feb 13, 2023Apr 28, 2023Jul 31, 2023Oct 30, 2023Jan 29, 2024Apr 29, 2024Jul 29, 2024Oct 28, 2024Feb 10, 2025Apr 28, 2025Jul 28, 2025Oct 27, 2025Jan 30, 2026May 8, 2026Jul 31, 2026
EPS Estimate1.422.021.411.662.894.103.033.904.454.644.584.725.706.225.235.625.996.715.716.346.536.195.284.915.095.835.125.90
EPS Actual1.782.621.301.992.893.993.214.215.155.185.124.875.985.914.815.235.217.346.516.095.585.136.234.025.095.496.067.08
Surprise25.35%29.70%-7.80%19.88%0.00%-2.68%5.94%7.95%15.73%11.64%11.79%3.18%4.91%-4.98%-8.03%-6.94%-13.02%9.39%14.01%-3.94%-14.55%-17.15%17.99%-18.13%0.00%-5.83%18.36%20.00%
TimingPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap32.58B
Enterprise Value27.97B
Trailing P/E17.99
Forward P/E0.00
Price / Sales4.17
Price / Book2.71
EPS23.57
Book Value150.52
Revenue (TTM)7.82B
Gross Profit (TTM)4.10B
EBITDA2.91B
Profit Margin23.56%
Operating Margin27.65%
Return on Equity16.51%
Return on Assets8.11%
Shares Outstanding76.84M
Shares Float39.82M
Beta0.81
Dividend Yield2.36%
Dividend Rate10.01
Payout Ratio42.18%

Dividends

20261×
10.01Aug 7, 2026
20251×
11.00Jun 12, 2025
20241×
10.00Jun 19, 2024
20231×
9.87Jun 8, 2023
20221×
8.39Jun 9, 2022
20211×
4.94Jun 10, 2021
20201×
2.47Jun 11, 2020
20191×
1.48Jul 22, 2019
20171×
0.99Aug 8, 2017